Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-23
1995-12-26
Jordan, Kimberly R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514454, 514455, 514456, 514457, 514458, 514568, 514570, 514571, 514622, A61K 3141, A61K 3135, A61K 31335, A61K 3119, A61K 31165
Patent
active
054788579
ABSTRACT:
This invention provides methods for the treatment or prevention of Alzheimer's disease in a mammal which comprises administering to a mammal in need thereof an effective amount of an inhibitor of phospholipase A.sub.2. This invention also provides a series of compounds which are useful as inhibitors of phospholipases A.sub.2, especially cytosolic phospholipase A.sub.2.
REFERENCES:
patent: 4814339 (1989-03-01), Rotondo
Clemens James A.
Sofia Michael J.
Stephenson Diane T.
Boone David E.
Eli Lilly and Company
Gaylo Paul J.
Jordan Kimberly R.
LandOfFree
Use of PLA.sub.2 inhibitors as treatment for alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of PLA.sub.2 inhibitors as treatment for alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of PLA.sub.2 inhibitors as treatment for alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369568